Clinical Trial Update: Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating tislelizumab in combination with SOX for gastric cancer with liver metastases; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Liver Metastases

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Zhejiang University | Conditions: Liver Metastases | Phase 2, Phase 3 | Status: UNKNOWN